Fairchem Organics Limited has informed the Exchange about Investor Presentation
FAIRCHEMOR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fairchem Organics reported Q4 FY26 revenue of INR 1,169 Mn (down 3.2% Y-o-Y) with EBITDA margin improving to 6.87% from 3.66% a year ago due to better domestic realizations. Full year FY26 revenue fell 14.5% to INR 4,596 Mn, with EBITDA down 49.5% to INR 216 Mn and PAT down 71.8% to INR 62 Mn. The company attributed the weak performance to subdued demand from the paints industry. Management provided FY30E targets and outlined four strategic priorities: cost optimization, product upgradation, new product development, and geographical diversification. The company aims to increase exports to 25-50% of sales, supported by favorable tariffs with the US and proposed FTAs with EU/UK. Fairfax India Holdings holds 63.26% stake.
The stock has underperformed significantly, down over 60% from its 52-week high of INR 1,100. The margin recovery in Q4 is a positive sign, but the steep decline in full-year profitability and uncertain macro environment due to Middle East crisis remain concerns for investors.